Management of the airway without the use of neuromuscular blocking agents: the use of remifentanil

被引：13

作者：

Fotopoulou, Georgia ^{[2
]}

Theocharis, Stamatios ^{[1
]}

Vasileiou, Ioanna ^{[1
]}

Kouskouni, Evangelia ^{[2
]}

Xanthos, Theodoros ^{[2
]}

机构：

[1] Univ Athens, Dept Forens Med & Toxicol, Sch Med, GR-11527 Athens, Greece

[2] Univ Athens, Sch Med, Lab Expt Surg & Surg Res, Athens, Greece

来源：

FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2012年 / 26卷 / 01期

关键词：

anesthesia; difficult airway; intubation; muscle relaxation; neuromuscular blockage; opioid; LARYNGEAL MASK AIRWAY; AWAKE FIBEROPTIC INTUBATION; TARGET-CONTROLLED INFUSION; RANDOMIZED CONTROLLED-TRIAL; RAPID-SEQUENCE INDUCTION; TOTAL INTRAVENOUS ANESTHESIA; TRACHEAL INTUBATION; MUSCLE-RELAXANTS; CONSCIOUS SEDATION; CARDIOVASCULAR-RESPONSES;

D O I：

10.1111/j.1472-8206.2011.00967.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Remifentanil belongs to opioid drugs, and its pharmacokinetic characteristics make it unique in this class of drugs and appropriate for use during intubation without neuromuscular blockage. This up-to-date review aims to summarize the findings of recent studies regarding remifentanil and intubation. Remifentanil combined either with propofol or with inhaled anesthetic agents has been proved to provide acceptable intubating conditions. Regarding children patients, remifentanil can be used safely, and as far as intubating conditions are concerned, its effectiveness is as excellent as with neuromuscular blockage. Strong evidence exists that illuminates the usefulness of the drug in cases of difficult airway as well as in neuromuscular diseases. Beyond all these favorable characteristics, anesthesiologists must be conscious with the use of remifentanil.

引用

页码：72 / 85

页数：14

共 102 条

[71] Fiberoptic intubation during remifentanil/propofol sedation [J].

Neidhart, G ;

Bremerich, DH ;

Kessler, P .

ANAESTHESIST, 2001, 50 (04) :242-247

[72] Remifentanil/propofol for fiberoptic intubation. A case report [J].

Neidhart G. ;

Kovács A.F. ;

Bremerich D.H. ;

Kessler P. .

Der Anaesthesist, 2000, 49 (6) :523-526

[73]

Nora Fernando Squeff, 2007, Rev. Bras. Anestesiol., V57, P247, DOI 10.1590/S0034-70942007000300003

[74] Dose-related attenuation of cardiovascular responses to tracheal intubation by intravenous remifentanil bolus in severe pre-eclamptic patients undergoing Caesarean delivery [J].

Park, B. Y. ;

Jeong, C. W. ;

Jang, E. A. ;

Kim, S. J. ;

Jeong, S. T. ;

Shin, M. H. ;

Lee, J. ;

Yoo, K. Y. .

BRITISH JOURNAL OF ANAESTHESIA, 2011, 106 (01) :82-87

[75] Remifentanil halves the EC50 of propofol for successful insertion of the laryngeal mask airway and laryngeal tube in pediatric patients [J].

Park, Hye-Jin ;

Lee, Jeong-Rim ;

Kim, Chong Sung ;

Kim, Seong Deok ;

Kim, Hee-Soo .

ANESTHESIA AND ANALGESIA, 2007, 105 (01) :57-61

[76] Effect of remifentanil on tracheal intubation conditions and haemodynamics in children anaesthetised with sevoflurane and nitrous oxide [J].

Park, K. S. ;

Park, S. Y. ;

Kim, J. Y. ;

Kim, J. S. ;

Chae, Y. J. .

ANAESTHESIA AND INTENSIVE CARE, 2009, 37 (04) :577-583

[77]

Politis George D, 2007, Paediatr Anaesth, V17, P285, DOI 10.1111/j.1460-9592.2006.02092.x

[78] Use of remifentanil for awake fiberoptic intubation in a morbidly obese patient with severe inflammation of the neck [J].

Puchner, W ;

Obwegeser, J ;

Pühringer, FK .

ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2002, 46 (04) :473-476

[79] Evaluation of remifentanil as single drug for awake fiberoptic intubation [J].

Puchner, W ;

Egger, P ;

Pühringer, F ;

Löckinger, A ;

Obwegeser, J ;

Gombotz, H .

ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2002, 46 (04) :350-354

[80] Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation:: a double-blinded randomized controlled trial [J].

Rai, M. R. ;

Parry, T. M. ;

Dombrovskis, A. ;

Warner, O. J. .

BRITISH JOURNAL OF ANAESTHESIA, 2008, 100 (01) :125-130

← 2 3 4 5 6 7 8 9 10 11 →